Introduction
============

Pleomorphic hyalinizing angiectatic tumors (PHATs) were first described by Smith *et al* ([@b1-ol-0-0-7929]) in 1996, and are rare mesenchymal tumors of uncertain lineage and intermediate malignancy ([@b1-ol-0-0-7929]--[@b3-ol-0-0-7929]). PHATs are defined by the presence of clusters of variably-sized thin-walled ectatic vessels that are infiltrated and surrounded by amorphous fibrin-rich hyaline material ([@b1-ol-0-0-7929],[@b2-ol-0-0-7929]). The angiectatic vessels characteristic of PHATs are surrounded by spindle-shaped, plump and round pleomorphic cells commonly arranged in sheets or, more rarely, in fascicles ([@b1-ol-0-0-7929]). Often, a subset of cells adjacent to the vessels contains intracytoplasmic hemosiderin. The pleomorphic cellular population is composed of large single and multinucleate cells with abundant cytoplasm, enlarged irregular nuclei and, in certain cases, large intranuclear inclusions ([@b1-ol-0-0-7929]). Mitotic figures are rare ([@b1-ol-0-0-7929]). PHATs contain a mixed chronic inflammatory infiltrate that is notable for the presence of mast cells, but also includes lymphocytes, plasma cells and eosinophils ([@b1-ol-0-0-7929],[@b3-ol-0-0-7929]). The main mass of a PHAT may be accompanied by a partially myxoid spindle-cell component on the periphery, a potential precursor lesion to a classical PHAT that was described as an early PHAT by Folpe and Weiss in 2004 ([@b2-ol-0-0-7929]). The first cytogenetic PHAT data published revealed an unbalanced translocation of chromosomes 1 and 3 and chromosomes 1 and 10, with breakpoints mapped to transforming growth factor-β receptor 3 (TGFBR3) and meningioma-expressed antigen 5 (MGEA5) ([@b4-ol-0-0-7929]). Subsequent fluorescence *in situ* hybridization and single nucleotide polymorphism analyses of PHATs demonstrated that some, but not all, are characterized by TGFBR3 and MGEA5 gene rearrangements ([@b5-ol-0-0-7929]--[@b7-ol-0-0-7929]).

There are few published reports describing the imaging appearance of PHATs. A PHAT typically appears as a soft tissue mass without osseous changes or calcification ([@b8-ol-0-0-7929]--[@b10-ol-0-0-7929]). In cases in which magnetic resonance imaging (MRI) is utilized, the PHAT presents as a soft-tissue mass that may be accompanied by edema or hematoma. The PHAT appears hypointense-isointense on T1-weighted sequences, heterogeneously isointense-hyperintense on T2-weighted sequences, and exhibits enhancement following administration of intravenous contrast ([@b4-ol-0-0-7929],[@b8-ol-0-0-7929],[@b11-ol-0-0-7929]--[@b18-ol-0-0-7929]). The current study presents an assessment of two patients with similar PHATs, and describes the key imaging, histological and immunophenotypical findings of these tumors.

Case reports
============

### Case A

A 50-year old male presented in 2016 to our institution with an 18-month history of an enlarging right buttock mass. The patient first noticed the mass following trauma and subjectively considered that the mass grew to be the size of a grapefruit. The patient denied experiencing any pain, except when sleeping on the right side; at the time of presentation, the patient was taking no pain medication and denied any radicular symptoms, night pain or weight loss. The patient also had normal muscle strength in the right lower extremity. A physical examination revealed a palpable, non-tender mobile mass in the right buttock. A contrast-enhanced computed tomography (CT) scan of the pelvis revealed an 8.0×7.7×8.6 cm heterogeneously enhancing subcutaneous soft tissue mass overlying the right gluteus maximus ([Fig. 1A](#f1-ol-0-0-7929){ref-type="fig"}). There was a prominent feeding artery noted as arising from the right profunda artery ([Fig. 1B](#f1-ol-0-0-7929){ref-type="fig"}). MRI was performed using a Siemens Verio 3T MRI machine (Siemens AG, Munich, Germany). T1-weighted sequences (repetition time (TR)/echo time (TE), 700/24 ms; slice thickness, 3 mm; interslice gap, 0.9 mm; acquisition matrix, 448×336); short-tau inversion recovery (STIR) sequences (TR/TE, 3400/48 ms; slice thickness, 3 mm; interslice gap, 0.9 mm; and acquisition matrix, 256×192); and T1-weighted contrast-enhanced sequences with fat saturation (TR/TE, 638/23 ms; slice thickness, 4 mm; interslice gap, 0.4 mm; and acquisition matrix 320×256) were obtained. T1-weighted imaging revealed the presence of a heterogeneous predominantly isointense mass ([Fig. 2A](#f2-ol-0-0-7929){ref-type="fig"}) with multiple areas of T1 signal hyperintensity (possibly representing areas of hemorrhage) and multiple areas of T1 signal hypointensity. The lesion was superficial to the right gluteus maximus fascia and present in the subcutaneous tissues ([Fig. 2B](#f2-ol-0-0-7929){ref-type="fig"}). Multiple flow voids consistent with small arteries were observed in the lesion ([Fig. 2C](#f2-ol-0-0-7929){ref-type="fig"}). There was no lymphadenopathy and no osseous involvement. The mass exhibited heterogeneous enhancement following administration of intravenous contrast ([Fig. 2D](#f2-ol-0-0-7929){ref-type="fig"}). The lesion was heterogeneously hypoechoic with internal globular and punctate hyperechoic foci when evaluated by ultrasound ([Fig. 3](#f3-ol-0-0-7929){ref-type="fig"}).

Histologic sections 5 µm thickness were deparaffinized and stained at room temperature with hematoxylin (5 min) and eosin (40 sec) on a Tissue Tek Prisma Automatic Stainer (Sakura Finetek USA, Inc., Torrance, CA, USA). On examination with light microscopy (variable objectives, magnification range 25--400×), the sections revealed a spindle cell lesion with sparsely sampled, hyalinized vessels. The cellular component was largely bland and spindled, with intermixed hemosiderin-laden macrophages and scattered large, atypical cells. Immunohistochemistry on formalin-fixed, paraffin-embedded tissue was performed using a Leica Bond-IIITM instrument using the Bond Polymer Refine Detection System according to the manufacturer\'s protocols (DS9800; Leica Microsystems, Inc., Buffalo Grove, IL, USA). Heat-induced epitope retrieval was performed for 20 min with ER1 or ER2 solution (Leica Biosystems) according to the manufacturer\'s protocols. The tissues were then incubated with the following primary antibodies at room temperature for 15 min: CD34 (ready to use dilution; cat no. PA0354; Leica Biosystems GmbH, Wetzlar, Germany), pancytokeratin (dilution 1:75; cat no. MU357-UC; BioGenex Laboratories, Inc., San Ramon, CA, USA), S100 (ready to use dilution; cat no. IR50461; Dako; Agilent Technologies, Inc., Santa Clara, CA, USA), smooth muscle actin (dilution, 1:600; cat no. M0851; Dako), epithelial membrane antigen (dilution, 1:100, cat no. M0613, Dako) and collagen IV (dilution 1:100; cat no. M0785; Dako). All interpretation of immunohistochemical stains was conducted with routine light-microscopy (variable magnification, ×25-400). On initial biopsies, immunohistochemical studies were inconclusive with respect to line of differentiation. No high-grade features were seen. Given the small sample size and the lack of definitive histological features, the non-specific diagnosis of 'spindle-cell neoplasm' was determined, with a differential diagnosis that included PHAT. Positron-emission tomography/computed tomography (PET/CT) demonstrated a mildly hypermetabolic lesion (maximum standardized uptake value of 4.2) with no evidence of hypermetabolic metastases ([Fig. 4](#f4-ol-0-0-7929){ref-type="fig"}). The lesion was resected with wide surgical margins. The excised specimen contained a circumscribed tumor with prominent thin-walled, hyalinized vessels ([Fig. 5](#f5-ol-0-0-7929){ref-type="fig"}). There were areas of hemorrhage and vascular thrombosis. An intermediate density of bland ovoid cells with rounded nuclear contour and occasional small nucleoli, along with admixed hemosiderin-laden cells and scattered large single- and multi-nucleated atypical cells was also observed. Mitotic activity was low (\<1/10 mitoses per high-power field). On the basis of these morphological findings, the patient was diagnosed with PHAT.

### Case B

A 72-year-old male presented to our institution in 2013 with a mass along the right buttock that had been slowly growing for almost 30 years. The mass was mildly uncomfortable when the patient sat. The patient also reported no unintentional weight loss or lymphadenopathy. A physical examination revealed a palpable, mobile, non-tender mass measuring approximately 10 cm in size. MRI was performed using a Siemens Espree 3T MRI (Siemens AG). T2-weighted sequences (TR/TE, 6,721/167 ms; slice thickness, 5 mm; interslice gap, 1 mm; and acquisition matrix, 320×320) and T1-weighted gradient imaging with fat saturation following administration of intravenous contrast (TR/TE, 170/2.37 ms; slice thickness, 5 mm; interslice gap, 1 mm; and acquisition matrix, 256×218) were obtained. The lesion was superficial to the fascia of the right gluteus maximus and measured \~6.3×10.4×10.2 cm. The lesion exhibited a heterogeneously hyperintense T2 intensity signal ([Fig. 6A](#f6-ol-0-0-7929){ref-type="fig"}) and heterogeneous enhancement following administration of intravenous contrast; there were two prominent arterial vessels originating from the right internal iliac artery supplying the lesion ([Fig. 6B and C](#f6-ol-0-0-7929){ref-type="fig"}). The patient underwent gross total resection of the tumor with negative margins. The histological findings were similar to those in case A, although this patient had reduced cellularity and more prominent areas of myxoid stroma ([Fig. 7](#f7-ol-0-0-7929){ref-type="fig"}). As in case A, the tumor was composed of a mixture of bland spindle cells with occasional large irregular cells that had retained cytoplasm and large atypical nuclei. There was no discernable mitotic activity or necrosis ([Fig. 7](#f7-ol-0-0-7929){ref-type="fig"}). In the immunohistochemical studies, the spindled tumor cells were positive for cluster of differentiation CD34 expression, focally positive for pancytokeratin expression, and negative for the expression of S100, smooth muscle actin, epithelial membrane antigen and collagen IV. The final histological diagnosis was a PHAT.

The requirement for patient consent for publication of the study was waived and ethical approval was provided by the Institutional Review Board of the University of Pennsylvania (Philadelphia, PA, USA).

Discussion
==========

To date, \<100 cases of PHAT have been reported worldwide ([@b14-ol-0-0-7929],[@b19-ol-0-0-7929]). The World Health Organization currently classifies PHAT as a benign neoplasm of uncertain differentiation ([@b3-ol-0-0-7929]). No reports of metastatic PHATs exist; however, it has been known to recur as sarcoma in rare cases ([@b2-ol-0-0-7929],[@b20-ol-0-0-7929]). Owing to its locally aggressive behavior and high recurrence rate (33--50%), it has been argued that a PHAT should be classified as a mesenchymal tumor of intermediate malignancy ([@b2-ol-0-0-7929]).

PHAT was first described by Smith *et al* ([@b1-ol-0-0-7929]) in 1996. The etiology of PHAT is not well understood and a number of competing theories persist regarding the formation of classic PHAT ([@b1-ol-0-0-7929]--[@b3-ol-0-0-7929]). The original description of the tumor by Smith *et al* ([@b1-ol-0-0-7929]) posited that the encroachment of a developing PHAT onto the vessels of healthy tissue leads to the release of the plasma contents of damaged endothelial cells, and precipitates a process of organization that results in the tumor\'s characteristic perivascular hyalinization ([@b1-ol-0-0-7929]). Smith *et al* ([@b1-ol-0-0-7929]) further proposed that the release of vasoactive mast cell products in response to tissue injury from a developing PHAT may be a cause of increased vessel permeability during development ([@b1-ol-0-0-7929]). Alternately, Folpe and Weiss ([@b2-ol-0-0-7929]) argue that early PHAT, characterized by low-medium spindle cell density, rare pleomorphic cells and myxoid extracellular matrix, is a precursor lesion to classic PHAT ([@b2-ol-0-0-7929]). PHAT typically presents in the subcutaneous tissues of the lower extremities, but may also develop intramuscularly, and has been documented in the arm, axilla, back, buccal mucosa, buttock, chest, hand, perineum, popliteal fossa and retroperitoneum ([@b2-ol-0-0-7929],[@b3-ol-0-0-7929],[@b13-ol-0-0-7929],[@b21-ol-0-0-7929]). The most common locations of PHATs, based on the published literature, include the leg (18/97; 18.6%), thigh (17/97; 17.5%), foot (14/97; 14.4%) and the ankle (10/97; 10.3%) ([@b1-ol-0-0-7929]--[@b41-ol-0-0-7929]). PHAT typically presents in adults; the cases presented in the published literature (97 patients) range in age from 10--89 years, with a median age of 57. PHAT demonstrates a slight predilection for females over males; the literature reviewed in the present study demonstrates a male to female ratio of 3:4 out of 97 reported cases ([@b2-ol-0-0-7929],[@b22-ol-0-0-7929],[@b23-ol-0-0-7929]). No information is currently available concerning race and, as \<10% of reported cases include this metric, no claims can be made regarding a predilection. [Table I](#tI-ol-0-0-7929){ref-type="table"} presents a list of all previously published cases of PHAT, including data on age, sex, race, tumor size, location and treatment ([@b1-ol-0-0-7929],[@b2-ol-0-0-7929],[@b4-ol-0-0-7929],[@b5-ol-0-0-7929],[@b8-ol-0-0-7929]--[@b41-ol-0-0-7929]).

PHAT often rises to medical attention following several years of slow growth ([@b1-ol-0-0-7929]--[@b3-ol-0-0-7929]). Upon clinical examination, PHAT typically presents grossly as an oval-round lobulated mass that varies in color from tan to maroon, and which may be associated with bruising or surrounding hematoma ([@b2-ol-0-0-7929],[@b9-ol-0-0-7929],[@b10-ol-0-0-7929]). PHAT may present as partially or predominantly cystic ([@b1-ol-0-0-7929],[@b12-ol-0-0-7929]), may be painless, painful or tender upon examination, and may be accompanied by necrosis in rare cases ([@b1-ol-0-0-7929],[@b14-ol-0-0-7929]).

The imaging appearance of PHAT is non-specific. Typical evaluation of any soft-tissue mass includes radiography of the region, followed by contrast-enhanced MRI evaluation and then by biopsy if clinically warranted. Limited imaging studies of PHAT exist in the literature and the majority of data are in the form of single case reports. In cases in which radiographs are published, there is consensus that PHAT typically appears as a soft tissue mass without osseous changes or calcifications; however, a single case with calcifications has been reported ([@b8-ol-0-0-7929]--[@b10-ol-0-0-7929],[@b14-ol-0-0-7929],[@b24-ol-0-0-7929]). To the best of our knowledge, only three examples of the ultrasound appearance of PHAT have been described in the literature ([@b18-ol-0-0-7929],[@b24-ol-0-0-7929],[@b25-ol-0-0-7929]). All three describe PHAT as a hypoechoic lesion with an internal hyperechogenic appearance, characterized by hyperechoic tissue interrupted by hypoechoic bands, which are presumably blood vessels ([@b18-ol-0-0-7929],[@b24-ol-0-0-7929],[@b25-ol-0-0-7929]). In reports of PHAT using MRI, the tumor presents as a soft tissue mass that may be accompanied by edema or hematoma ([@b8-ol-0-0-7929],[@b11-ol-0-0-7929]--[@b15-ol-0-0-7929]). PHAT appears hypointense to isointense with T1 weighting, heterogeneously hyperintense to isointense with T2 weighting, and exhibits heterogeneous enhancement following the intravenous administration of gadolinium-based contrast ([@b4-ol-0-0-7929],[@b8-ol-0-0-7929],[@b11-ol-0-0-7929]--[@b13-ol-0-0-7929],[@b16-ol-0-0-7929]--[@b18-ol-0-0-7929]). PHATs with well-demarcated and infiltrative borders have previously been described in the literature ([@b9-ol-0-0-7929],[@b12-ol-0-0-7929]). The two cases presented in the current study exhibited prominent borderline ectatic arterial vessels supplying the tumors and well-demarcated tumor borders. The imaging differential diagnosis includes subcutaneous metastasis, melanoma or a soft tissue sarcoma.

PHAT is notable for the presence of clusters of ectatic vessels surrounded by fibrin-rich hyaline material and cuffed by lamellae of collagen that extend into the mass of the tumor and trap individual cells, potentially forming pockets of hyalinized material ([@b1-ol-0-0-7929],[@b2-ol-0-0-7929]). PHATs contain spindle-shaped, plump and round pleomorphic cells ([@b1-ol-0-0-7929],[@b2-ol-0-0-7929]). Cells exhibit hyperchromasia, nuclear pleiomorphism and a lack of cytoplasmic differentiation; they may also contain hemosiderin, nuclear inclusions and cytoplasmic vimentin filaments ([@b9-ol-0-0-7929],[@b26-ol-0-0-7929]). Immunohistochemical analysis of PHATs typically reveal the presence of CD34 and may also detect expression of vimentin, B-cell lymphoma 2, factor XIIIa, vascular endothelial growth factor and CD99; PHAT lacks expression of S-100 protein, CD31, von Willebrand Factor, smooth muscle actin, desmin and epithelial membrane protein ([@b1-ol-0-0-7929],[@b2-ol-0-0-7929],[@b11-ol-0-0-7929],[@b22-ol-0-0-7929],[@b27-ol-0-0-7929]). PHAT cells stained for Ki-67 rarely exhibit positive staining, consistent with the histological observation of few mitotically active cells ([@b1-ol-0-0-7929],[@b22-ol-0-0-7929]). Histological differential diagnoses include neurilemmoma, undifferentiated pleomorphic sarcoma (UPS), giant-cell angiofibroma and solitary fibrous tumor (SFT) ([@b1-ol-0-0-7929],[@b3-ol-0-0-7929],[@b11-ol-0-0-7929],[@b22-ol-0-0-7929],[@b23-ol-0-0-7929]). PHAT can be distinguished from neurilemmoma by the absence of S-100, lack of encapsulation, and the absence of Antoni A and B areas ([@b11-ol-0-0-7929],[@b22-ol-0-0-7929]). PHAT can be distinguished from UPS by its infrequent mitotic figures and the presence of nuclear inclusions ([@b1-ol-0-0-7929],[@b9-ol-0-0-7929],[@b22-ol-0-0-7929]). PHAT can be distinguished from by the presence of clusters of thin-walled vessels, atypical cells with bland cytoplasm and intranuclear inclusions ([@b11-ol-0-0-7929]).

Wide local excision with tumor free margins is the recommended treatment for PHAT ([@b1-ol-0-0-7929],[@b2-ol-0-0-7929],[@b16-ol-0-0-7929]) as they may occur as a collision tumor with sarcomas such as myxofibrosarcomas ([@b20-ol-0-0-7929]). Surgical excision may be combined with low dose radiation to reduce the risk of local recurrence ([@b1-ol-0-0-7929],[@b2-ol-0-0-7929],[@b4-ol-0-0-7929]). The patients were followed with serial imaging, as these lesions have a tendency to locally recur. One patient was followed lost to follow up after one year, and the other remains under active imaging surveillance (follow up of 1 year).

The present study reported and discusses the ultrasound, CT, MRI and PET/CT imaging appearance and correlating histology of two histologically verified cases of PHAT. Biopsy remains a requirement because imaging features are non-specific.
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![(A) Axial contrast-enhanced CT image of the pelvis indicating a heterogeneously enhancing mass in the subcutaneous tissues superficial to the right gluteus maximus (white arrow) from case A. (B) Axial contrast-enhanced CT image of the pelvis indicating a prominent artery (white asterisk) arising from the right profunda artery and supplying the heterogeneously enhancing mass in the subcutaneous tissues superficial to the right gluteus maximus. CT, computed tomography.](ol-15-04-4720-g00){#f1-ol-0-0-7929}

![(A) Axial T1-weighted MR image of the pelvis depicting a T1-heterogeneous mass (white arrow) with areas of internal T1-hyperintensity and T1-hypointensity from the patient (case A). (B) Coronal STIR MR image of the pelvis indicating a heterogeneously T2-hyperintense subcutaneous mass (white arrow) along the right gluteus maximus fascia. (C) Axial STIR MR image of the pelvis indicating multiple flow voids within the mass consistent with small vessels. (D) Coronal T1-weighted MR image of the pelvis following administration of intravenous contrast with fat saturation indicating a heterogeneously enhancing mass along the fascia of the right gluteus maximus (white arrow). MR, magnetic resonance; STIR, short tau inversion recovery sequence.](ol-15-04-4720-g01){#f2-ol-0-0-7929}

![Transverse sonographic image (5 MHz) of the right buttock from the patient (case A) depicting a heterogeneously hypoechoic mass with hyperechoic rim and internal globular and punctate hyperechoic foci (white arrows).](ol-15-04-4720-g02){#f3-ol-0-0-7929}

![Coronal fused positron emission tomography/computed tomography image of the patient (case A)indicating a mildly FDG-avid mass along the right buttock (white arrow). No other foci of abnormal increased FDG activity were noted. FDG, ^18^F-fludeoxyglucose](ol-15-04-4720-g03){#f4-ol-0-0-7929}

![Histological findings in case A, hematoxylin and eosin. (A) At an intermediate magnification (×100), the tumor consists of a spindle cell tumor with large, thin walled vessels and nascent thrombus formation. The vessel walls are surrounded by prominent hyaline material (arrowheads). There are areas of hemorrhage and a mild, chronic inflammatory infiltration and scattered atypical cells. (B) At a higher magnification (×200), hemosiderin-laden mononuclear phagocytes (arrowheads) and (C) large atypical cells (arrowhead) are apparent.](ol-15-04-4720-g04){#f5-ol-0-0-7929}

![(A) Axial T1-weighted MR image of the pelvis without fat saturation depicting a heterogeneously T1 hyperintense lesion (white arrow) with mass effect on the right gluteus maximus from the patient (case B). There are areas of internal increased T1 signal suggestive of fat or hemorrhage. (B) Axial T1-weighted MR image of the pelvis with fat saturation following administration of intravenous contrast depicting a heterogeneously enhancing mass along the right gluteus maximus without invasion of the gluteus maximus (white arrow) and two prominent feeding arterial vessels (white asterisks). (C) Axial T1-weighted MR image of the pelvis with fat saturation following administration of intravenous contrast depicting a heterogeneously enhancing mass along the right gluteus maximus without invasion of the gluteus maximus (white arrow) and two prominent feeding arterial vessels (white asterisks). MR, magnetic resonance.](ol-15-04-4720-g05){#f6-ol-0-0-7929}

![Histological findings in case B, hematoxylin and eosin. (A) At a low magnification (×50), the tumor is similar in appearance to case A, although with more variable cellularity and a more pronounced gray-blue myxoid stroma. (B) The thin, ectatic vessels contain perivascular hyaline material (arrowheads; magnification, ×100). There are admixed large, atypical cells visible at low magnification and (C) highlighted at higher magnification (arrowheads; magnification, ×200).](ol-15-04-4720-g06){#f7-ol-0-0-7929}

###### 

List of published studies of PHAT.

  Author, year                    Sex   Age   Race               Location        Treatment                                                                                                                                    Imaging                  Size, cm           Pre-operative duration   (Refs.)
  ------------------------------- ----- ----- ------------------ --------------- -------------------------------------------------------------------------------------------------------------------------------------------- ------------------------ ------------------ ------------------------ ----------------------
  Smith *et al*, 1996             M     33    NR                 Shoulder        Wide excision + XRT                                                                                                                          NR                       3.5                NR                       ([@b1-ol-0-0-7929])
                                  F     78    NR                 Leg             Local excision then amputation                                                                                                               NR                       8                  NR                       
                                  F     62    NR                 Chest wall      Simple excision + XRT                                                                                                                        NR                       2.5                NR                       
                                  F     33    NR                 Ankle           Excision + XRT                                                                                                                               NR                       5.5                NR                       
                                  M     70    NR                 Thigh           Simple excision                                                                                                                              NR                       4.5                NR                       
                                  F     32    NR                 Leg             Simple excision                                                                                                                              NR                       NR                 NR                       
                                  F     59    NR                 Thigh           Anucleation                                                                                                                                  NR                       6                  NR                       
                                  M     72    NR                 Thigh           Simple excision                                                                                                                              NR                       4.5                NR                       
                                  M     60    NR                 Thigh           Excision                                                                                                                                     NR                       6                  NR                       
                                  F     58    NR                 Chest wall      NR                                                                                                                                           NR                       ≥2                 NR                       
                                  F     78    NR                 Arm             Simple excision                                                                                                                              NR                       Recurrence, 6      NR                       
                                  M     57    NR                 Buttock         Excision                                                                                                                                     NR                       NR                 NR                       
                                  M     83    NR                 Thigh           Excision                                                                                                                                     NR                       2.3                NR                       
                                  F     51    NR                 Ankle           Excision                                                                                                                                     NR                       Recurrence, ≥2.5   NR                       
  Folpe and Weiss, 2004           F     39    NR                 Hand            NA                                                                                                                                           NR                       NR                 Unknown                  ([@b2-ol-0-0-7929])
                                  F     30    NR                 Ankle           Local excision                                                                                                                               NR                       NR                 Unknown                  
                                  M     42    NR                 Forearm         Wide excision and XRT                                                                                                                        NR                       NR                 Many years               
                                  F     46    NR                 Foot            Wide excision                                                                                                                                NR                       13                 Unknown                  
                                  M     10    NR                 Foot            Wide excision                                                                                                                                NR                       NR                 1 year                   
                                  F     51    NR                 Ankle           Local excision, then wide excision and XRT                                                                                                   NR                       NR                 Unknown                  
                                  F     44    NR                 Ankle           Local excision                                                                                                                               NR                       'Large'            Unknown                  
                                  M     67    NR                 Leg             NA                                                                                                                                           NR                       4                  Unknown                  
                                  F     32    NR                 Leg             NA                                                                                                                                           NR                       6                  Unknown                  
                                  M     36    NR                 Thigh           Local excision                                                                                                                               NR                       7                  Unknown                  
                                  F     50    NR                 Ankle           Local excision                                                                                                                               NR                       2.5                2 months                 
                                  F     53    NR                 Foot            NA                                                                                                                                           NR                       7                  Unknown                  
                                  F     84    NR                 Leg             NA                                                                                                                                           NR                       0.3                Unknown                  
                                  F     57    NR                 Foot            Wide excision                                                                                                                                NR                       10.2               16 years                 
                                  F     49    NR                 Leg             Local excision                                                                                                                               NR                       NR                 Unknown                  
                                  M     56    NR                 Axilla          NA                                                                                                                                           NR                       NR                 Unknown                  
                                  M     49    NR                 Thigh           Local excision                                                                                                                               NR                       NR                 Unknown                  
                                  M     79    NR                 Pelvis          Local excision, then wide excision and XRT                                                                                                   NR                       14                 Unknown                  
                                  M     60    NR                 Ankle           NA                                                                                                                                           NR                       5                  2--3 years               
                                  M     27    NR                 Thigh           NA                                                                                                                                           NR                       5.6                Many years               
                                  M     66    NR                 Ankle           Local excision, then wide excision and XRT                                                                                                   NR                       7                  6 months                 
                                  M     54    NR                 Foot            Local excision followed by amputation following recurrence                                                                                   NR                       3.2                Unknown                  
                                  F     32    NR                 Leg             Local excision and re-excision                                                                                                               NR                       5                  2 years                  
                                  F     46    NR                 Leg             Local excision and re-excision                                                                                                               NR                       2                  Unknown                  
                                  F     77    NR                 Thigh           Local excision and re-excision                                                                                                               NR                       14                 Unknown                  
                                  F     79    NR                 Foot            Wide excision                                                                                                                                NR                       1.8                Unknown                  
                                  F     77    NR                 Thigh           NA                                                                                                                                           NR                       4.2                3 months                 
                                  M     67    NR                 Arm             NA                                                                                                                                           NR                       5.8                Unknown                  
                                  M     89    NR                 Leg             Local excision and re-excision                                                                                                               NR                       3.5                Unknown                  
                                  M     74    NR                 Buttock         Local excision and re-excision                                                                                                               NR                       5.5                Unknown                  
                                  F     75    NR                 Thigh           NA                                                                                                                                           NR                       NR                 2 years                  
                                  M     49    NR                 Inguinal        NA                                                                                                                                           NR                       4                  Many years               
                                  M     63    NR                 Inguinal        NA                                                                                                                                           NR                       11                 3 years                  
                                  F     38    NR                 Back            NA                                                                                                                                           NR                       3                  Unknown                  
                                  F     51    NR                 Foot            NA                                                                                                                                           NR                       6.5                Unknown                  
                                  M     32    NR                 Arm             NA                                                                                                                                           NR                       6                  Unknown                  
                                  M     44    NR                 Buttock         Local excision and re-excision                                                                                                               NR                       'Large'            11 years                 
                                  F     67    NR                 Ankle           Local excision and re-excision                                                                                                               NR                       6.1                Unknown                  
                                  F     59    NR                 Leg             Local excision, then wide excision and XRT                                                                                                   NR                       6.5                Unknown                  
                                  F     42    NR                 Foot            Local excision followed by wide excision following recurrence                                                                                NR                       2                  Unknown                  
                                  M     43    NR                 Leg             Wide excision                                                                                                                                NR                       20                 20 years                 
  Wei *et al*, 2012               F     37    Caucasian          Foot            Surgical resection followed by two subsequent re-excisions and external beam radiation to a total of 60 Gy in 30 fractions for recurrences   MRI                      5                  NR                       ([@b4-ol-0-0-7929])
  Mohajeri *et al*, 2012          F     58    NR                 Foot            Surgical excision with a marginal margin                                                                                                     NR                       0.3×1.5×1.5        1 year                   ([@b5-ol-0-0-7929])
                                  M     33    NR                 Thigh           Surgical excision with a narrow margin                                                                                                       NR                       0.5×3.5×2.5        NR                       
  Suzuki *et al*, 2014            F     68    NR                 Thigh           Wide resection was performed for the internal lesion, whereas an intralesional resection was performed for the outer lesion                  Radiography, MRI         10.5×4.5×3.5       2 months                 ([@b8-ol-0-0-7929])
  Cimino-Mathews and Ali, 2011    M     46    NR                 Leg             Wide local surgical excision                                                                                                                 Radiograph               3×1×1              2 months                 ([@b9-ol-0-0-7929])
  Illueca *et al*, 2012           F     37    NR                 Ankle           Surgical excision                                                                                                                            X-ray                    3.5×2×1.5          2 months                 ([@b10-ol-0-0-7929])
  Lin and Crapanzano, 2005        F     45    NR                 Thigh           Surgical excision                                                                                                                            MRI                      3.5×2.8×1.5        3 months                 ([@b11-ol-0-0-7929])
  Subhawong *et al*, 2012         M     46    Hispanic           Leg             Radical excision                                                                                                                             MRI                      1.9×1.7×2.1        NR                       ([@b12-ol-0-0-7929])
                                  F     49    African American   Foot            Radical resection                                                                                                                            MRI                      9.5×3.4×7.0        4 years                  
                                  F     87    NR                 Arm             Surgical resection                                                                                                                           MRI                      4.8×4.6×5.8        3 years                  
  Chu *et al*, 2016               F     26    NR                 Pelvis          Radical excision                                                                                                                             MRI, CT                  9.4×9.1×9.5        Unknown                  ([@b13-ol-0-0-7929])
  Brazio *et al*, 2016            M     22    NR                 Forearm         Excise without wide margins (to retain hand function)                                                                                        MRI                      16.7×24.2×26       2 years                  ([@b14-ol-0-0-7929])
  Felton and Ramlogan, 2015       M     62    NR                 Leg             NR                                                                                                                                           MRI                      5×6                5 years                  ([@b15-ol-0-0-7929])
  Lee *et al*, 2005               M     63    NR                 Breast          Total mastectomy radiology                                                                                                                   MRI,                     25.6×8.3×26.3      4 years                  ([@b16-ol-0-0-7929])
  Fujiwara *et al*, 2004          M     69    Asian (Japanese)   Back            Surgical resection                                                                                                                           MRI                      7                  23 years                 ([@b17-ol-0-0-7929])
  Fukunaga and Ushigome, 1997     M     58    Asian (Japanese)   Axilla          Marginal Excision                                                                                                                            Ultrasound, MRI, X-Ray   8                  2 months                 ([@b18-ol-0-0-7929])
  Changchien *et al*, 2014        M     76    Hungarian          Arm             Surgical removal                                                                                                                             NR                       4.6×4.5×3          5 months                 ([@b19-ol-0-0-7929])
  Kazakov *et al*, 2007           F     76    NR                 Axilla          Surgical excision                                                                                                                            NR                       3.5                Unknown                  ([@b20-ol-0-0-7929])
  Ide *et al*, 2004               F     86    NR                 Buccal mucosa   Surgical excision                                                                                                                            NR                       3×3×2              2.5 years                ([@b21-ol-0-0-7929])
  El-Tal and Mehregan, 2005       F     60    NR                 Foot            Surgical excision                                                                                                                            NR                       2.2×2.1×1.1        NR                       ([@b22-ol-0-0-7929])
  Matsumoto and Yamamoto, 2002    F     83    NR                 Thigh           Surgical resection                                                                                                                           NR                       5.0×5.0×2.0        10 years                 ([@b23-ol-0-0-7929])
  Tallarigo *et al*, 2009         M     75    NR                 Breast          Radical mastectomy and axillary node clearance                                                                                               Mammograph, ultrasound   8                  Several years            ([@b24-ol-0-0-7929])
  Labanaris *et al*, 2011         M     68    NR                 Scrotum         Inguinal radical orchiectomy with high ligation of the spermatic cord                                                                        Ultrasound, CT           18×15              NR                       ([@b25-ol-0-0-7929])
  Capovilla *et al*, 2006         M     66    NR                 Buttock         Surgical excision                                                                                                                            NR                       4                  NR                       ([@b26-ol-0-0-7929])
  Groisman *et al*, 2000          F     41    NR                 Leg             Simple excision for diagnosis then wide local excision                                                                                       NR                       NR                 3 years                  ([@b27-ol-0-0-7929])
                                  F     44    NR                 Leg             Simple excision for diagnosis then wide local excision                                                                                       NR                       NR                 1 year                   
  Gallo *et al*, 1997             F     88    NA                 Thigh           NA                                                                                                                                           NA                       NA                 NA                       ([@b28-ol-0-0-7929])
  Silverman and Dana, 1997        F     59    NR                 Foot            Local Excision                                                                                                                               NR                       2                  Unknown                  ([@b29-ol-0-0-7929])
  Husek and Veselý, 2001          M     63    NA                 Forearm         Surgical excision                                                                                                                            NA                       4.0×3.5×2.5        NA                       ([@b30-ol-0-0-7929])
  Jaggon and Aitken, 2007         F     77    NR                 Flank           Wide local excision                                                                                                                          NR                       8×6                2 years                  ([@b31-ol-0-0-7929])
  Parameshwarappa *et al*, 2010   F     65    NR                 Forearm         Wide local excision                                                                                                                          NR                       5×4                13 years                 ([@b32-ol-0-0-7929])
  Peng *et al*, 2010              M     49    NR                 Buttock         Surgical excision followed by wide excision for recurrence                                                                                   CT of recurrence         14×6×3.5           NR                       ([@b33-ol-0-0-7929])
  Idrees *et al*, 2013            F     71    Caucasian          Renal Hilum     Right radical nephrectomy and limited retroperitoneal lymph node dissection                                                                  CT                       4.2×6              NR                       ([@b34-ol-0-0-7929])
  Kuang, 2013                     F     35    NR                 Neck            Surgical removal                                                                                                                             CT                       3.4×4×5            6 months                 ([@b35-ol-0-0-7929])
  Rekhi and Aggarwal, 2013        F     63    NR                 Leg             Surgical resection                                                                                                                           NR                       4×3×3              3--4 years               ([@b36-ol-0-0-7929])
  Fan *et al*, 2015               F     51    NR                 Chest wall      NR                                                                                                                                           NR                       2×1                1 year                   ([@b37-ol-0-0-7929])
  Morency *et al*, 2015           F     55    NR                 Foot            NA                                                                                                                                           NA                       NA                 NA                       ([@b38-ol-0-0-7929])
  Yorita *et al*, 2015            M     56    Asian (Japanese)   Thigh           Surgical resection                                                                                                                           CT                       6.5×3.8×3.5        8 months                 ([@b39-ol-0-0-7929])
  Kane *et al*, 2016              M     35    NA                 Hand            Surgical excision                                                                                                                            NA                       NA                 NA                       ([@b40-ol-0-0-7929])
  Onyemkpa and Oyasiji, 2016      F     79    African American   Inguinal        Wide local                                                                                                                                   CT excision              4.9×7.2×10.7       7 years                  ([@b41-ol-0-0-7929])

PHAT, Pleomorphic hyalinizing angiectatic tumors; NR, not reported; XRT, radiation therapy; MRI, magnetic resonance imaging; CT, computed tomography; NA, not applicable.
